Piyali Khamkat, Abhishek Ghosh, Swarupananda Mukherjee
Piyali Khamkat1, Abhishek Ghosh2, Swarupananda Mukherjee3
1Department of Pharmaceutical Technology, Brainware University, 398, Ramkrishnapur Road, Barasat, Kolkata -125, India.
2Bengal College of Pharmaceutical Sciences and Research, Basu Sarani Burdwan, Bidhannagar, Durgapur, West Bengal -713212, India.
3NSHM Knowledge Campus, Kolkata – Group of Institutions, Department of Pharmaceutical Technology, 124, B.L Saha Road, Kolkata 700053.
Volume - 15,
Issue - 6,
Year - 2022
One may find difficulties with oral and parenteral drug delivery systems in a routine of clinical practice because they do not have sufficient compliance and bioavailability for patients. So, nowadays transdermal route is a greater area of interest of pharmaceutical research for delivering drug. But skin is the most challenging area to cross in transdermal delivery of drug as the stratum corneum & the outer layer of the skin have tight intracellular junctions. Researchers have developed various approaches like micro needle, sonophoresis, electrophoresis, and iontophoresis etc to overcome those complications for the transdermal delivery of drugs. Chemical permeation enhancers are needed in vesicular drug delivery system such as niosomes, liposomes, elastic liposomes (transfersomes and ethosomes) to improve their penetration property. Transferosomes can be prepared by a number of methods like vortexing, sonication method, freeze–thaw method, ethanol injection method, Reverse-phase evaporation method, etc. Transfersomes can carry wide ranges of drugs having a wide range of solubility within it as they are constructed of hydrophobic as well as hydrophilic moieties. The main property of transferosome is deformability. This flexible nature of the vesicle membrane helps transfersome to go across the narrow pores with a maximum amount of drugs present within it. They have high deformable capacity which exhibits advanced penetration capability of intact vesicles. Both high and low molecular weight drugs like albumin, insulin, corticosteroids, sex hormones, anesthetic, anticancer, analgesic can be fused within transfersome.
Cite this article:
Piyali Khamkat, Abhishek Ghosh, Swarupananda Mukherjee. Transfersomes: An Innovative Vesicular Carrier for Boosted Transdermal Delivery System. Research Journal of Pharmacy and Technology. 2022; 15(6):2793-0. doi: 10.52711/0974-360X.2022.00467
Piyali Khamkat, Abhishek Ghosh, Swarupananda Mukherjee. Transfersomes: An Innovative Vesicular Carrier for Boosted Transdermal Delivery System. Research Journal of Pharmacy and Technology. 2022; 15(6):2793-0. doi: 10.52711/0974-360X.2022.00467 Available on: https://rjptonline.org/AbstractView.aspx?PID=2022-15-6-71
1. Robinson JR and Lee VHL. In controlled drug delivery: fundamental applications. Journal of Pharmaceutical Sciences. 1987; 2: 739.
2. Jain S, Patel N, Shah MK, et al. Recent advances in lipid-based vesicles and particulate carriers for topical and transdermal application. Journal of Pharmaceutical Sciences. 2016; 116: 1-23.
3. Dayan N, Touitou E. Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs. liposomes. Biomaterials. 2000; 21: 1879-1885.
4. Madoria N, Pathodiya1 M, Tiwari A. Aceclofenac Loaded Vesicles: A Comparative Study between Various Vesicular Systems. Research Journal of Pharmacy and Technology. 2012; 5: 1130-1138.
5. Pawar JS, Roge AB, Vadvalkar SM. Novel Approach in Transdermal Drug Delivery System: Transferosome. Research Journal of Pharmacy and Technology. 2013; 6: 17-21.
6. Aujla M, Rana AC, Bala R, et al. Comparative Potential of Vesicular Carriers for Transdermal Drug Delivery: A Review. Research Journal of Pharmacy and Technology. 2012; 5: 302-306.
7. Zheng W, Fang Xia Wang L, et al. Preparation and quality assessment of itraconazole transfersomes. International Journal of Pharmaceutics. 2012; 436: 291-298.
8. Sahu SK, Ram A. Evaluation of Linezolid Loaded Ethosomes for Treatment of Deep Skin Infections in Diabetic Model. Research Journal of Pharmacy and Technology. 2018; 11: 3023-3030.
9. Jondhalekar TM, Aher SS, Saudagar RB. Transethosome: Novel Vesicular Carrier for Enhanced Transdermal Drug Delivery System. Research Journal of Pharmacy and Technology. 2017; 10: 1816-1819.
10. Aujla M,. Rana AC, Bala R, et al. Comparative Potential of Vesicular Carriers for Transdermal Drug Delivery: A Review. Research Journal of Pharmacy and Technology. 2012; 5 : 302-306.
11. Sindhu1 RK, Chitkara M, Kaur G, et al. Skin Penetration Enhancer’s in Transdermal Drug Delivery Systems. Research Journal of Pharmacy and Technology. 2017; 10: 1809-1815.
12. Mahor S, Rawat A, Dubey PK, et al. Cationic transfersomes based topical genetic vaccine against hepatitis B. International Journal of Pharmaceutics. 2007; 340: 13-19.
13. Lal N, Verma N. Development and Evaluation of Transdermal Patches containing Carvedilol and Effect of Penetration Enhancer on Drug Release. Research Journal of Pharmacy and Technology. 2018; 11:745-752.
14. Jain S, Jain P, Umamaheshwari RB, et al. Transfersomes–a novel vesicular carrier for enhanced transdermal delivery: development, characterization and performance evaluation. Drug Development and Industrial Pharmacy. 2003; 29: 1013-1026.
15. Monisha C, Ganesh GNK, Mythili L, et al. Review on Ethosomes for Transdermal Application. Research Journal of Pharmacy and Technology. 2019; 12: 3133-3143.
16. Mishra D, Garg M, Dubey V, et al. Elastic liposomes mediated transdermal delivery of an anti-hypertensive agent: propranolol hydrochloride. Journal of Pharmaceutical Sciences. 2007; 96: 145-155.
17. Cevc G, Blume G. Lipid vesicles penetrate into skin owing to the transdermal osmotic gradients and hydration force. Biochimica et Biophysica Acta. 1992; 1104: 226-232.
18. Cevc G, Blume G. New highly efficient formulation of diclofenac for the topical, transdermal administration in ultradeformable drug carriers, transfersomes. Biochimica et Biophysica Acta. 2001; 1514: 191-205.
19. Biju SS, Talegaonkar S, Mishra PR, et al. Vesicular system an overview. Indian Journal of Pharmaceutical Sciences. 2006; 68: 141-153.
20. Hofer C, Hartung R, Gobel R, et al. New ultradeformable drug carriers for potential transdermal application of interleukin-2 and interferon-alpha: theoretic and practical aspects. World Journal of Surgery. 2000; 24: 1187-1189.
21. Gavali SM, Pacharane SS, Jadhav KR, et al. Clinical transfersome: a new technique for transdermal drug delivery. International Journal of Research in Pharmacy and Chemistry. 2011; 1: 735-740.
22. Roge AB, Sakhare RS, Bakal RL, et al. Ethosomes: Novel Approach in Transdermal Drug Delivery System. Research Journal of Pharmaceutical Dosage Forms and Technology. 2010; 2: 23-27.
23. Mallina SA, Sundararajan R. Diclofenac sodium loaded liposomal gel for transdermal delivery: Formulation, characterisation and pharmacokinetic evaluation. Research Journal of Pharmacy and Technology. 2018; 11: 4051-4062.
24. Bangham AD, Standish MM, Watkins JC. Diffusion of univalent ions across the lamellae of swollen phospholipids. Journal of Molecular Biology. 1965; 13: 238-252.
25. Charcosset C, Juban A, Valour JP, et al. Preparation of liposomes at large scale using the ethanol injection method: effect of scale-up and injection devices. Chemical Engineering Research and Design. 2015; 94: 508-515.
26. Sazoka F, Papahadjopoulos D. Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. Proceedings of the National Academy of Sciences of the United States of America. 1978; 75: 4194-4198.
27. Rai K. Transfersomes: self-optimizing carriers for bioactives. PDA Journal of Pharmaceutical Science and Technology. 2008; 62: 362-379.
28. Maestrelli F, Rodriguez M, Rabasco A, et al. Effect of preparation techniques on the properties of liposomes encapsulating ketoprofen- cyclodextrine complexes aimed for transdermal delivery. International Journal of Pharmaceutics. 2006; 312: 53-60.
29. Johnston MJ, Edwards K, Karlsson G, et al. Influence of drug-to-lipid ratio on drug release properties and liposome integrity in liposomal doxorubicin formulations. Journal of Liposome Research. 2008; 18: 145-157.
30. Lachman L, Liebermann HA, Kanig JL. The theory and practice of industrial pharmacy. 3rd edition.Stipes Publishing; 1986. P. 902.
31. Kaur CD, Saraf S. Topical vesicular formulations of Curcuma longa extract on recuperating the ultraviolet radiation-damaged skin. Journal of Cosmetic Dermatology. 2011; 10: 260-265.
32. Gmm EM, Williams AC, Barry BW. Skin delivery of 5- fluorouracil from ultradeformable and standard liposomes in-vitro. Journal of Pharmacy and Pharmacology. 2001; 53: 1069-1077.
33. Malakar J, Sen SO, Nayak AK, et al. Formulation, optimization and evaluation of transferosomal gel for transdermal insulin delivery. Saudi Pharmaceutical Journal. 2012; 20: 355-363.
34. Alvi IA, Madan J, Kaushik D, et al. Comparative study of transfersomes, liposomes, and niosomes for topical delivery of 5-fluorouracil to skin cancer cells: preparation, characterization, in-vitro release, and cytotoxicity analysis. Anticancer Drugs. 2011; 8: 774-782.
35. Walve JR, Bakliwal SR, Rane BR, et al. Transfersomes: a surrogated carrier for transdermal drug delivery system. International Journal of Applied Biology and Pharmaceutical Technology. 2011; 2: 204-213.
36. Badran M, Shalaby K, Al-Omrani A. Influence of the flexible liposomes on the skin deposition of a hydrophilic model drug, carboxyfluorescein: dependency on their composition. The Scientific World Journal. 2012; 2012: 1-9.
37. Ravi K, Singh M, Bala R, et al. Transferosomes: a novel approach for transdermal drug delivery. International Research Journal of Pharmacy. 2012; 3: 20-24.
38. Maurya SD. Enhanced transdermal delivery of Indinavir sulphate via transfersomes. The International Journal of Pharmaceutical Compounding. 2010; 1: 1-7.
39. Abdallah M. Transferosomes as a transdermal drug delivery system for enhancement the antifungal activity of nyastatin. International Journal of Pharmacy and Pharmaceutical Sciences. 2013; 5: 560-567.
40. Madhumitha V, S. Sangeetha. Transfersomes: A Novel Vesicular Drug Delivery System for Enhanced Permeation through Skin. Research Journal of Pharmacy and Technology. 2020; 13: 2493-2501
41. Solanki D, Kushwah L, Motiwale M, et al. Transferosomes- a review. World Journal of Pharmaceutical Sciences. 2016; 5: 435-449.
42. Gupta A, Aggarwal G, Singla S, et al. Transfersomes: a novel vesicular carrier for enhanced transdermal delivery of sertraline: development, characterization, and performance evaluation. Scientia Pharmaceutica. 2012; 80: 1061-1080.
43. Ammar HO, Ghorab M, Nahhas SA, et al. Proniosomes as a carrier system for transdermal delivery of tenoxicam. International Journal of Pharmaceutics. 2011; 405: 142-152.
44. Bhowmik M, Sanchita D, Chattopadhyay D, et al. Study of thermo-sensitive in-situ gels for ocular delivery. Scientia Pharmaceutica. 2011; 79: 351-358.
45. Rathore P, Duggal S. Transferosomes: a novel carrier for transdermal drug delivery system. International Journal of Pharmacy Research & Technology. 2012; 4: 1854-1865.
46. Verma DD, Verma S, Blume G, et al. Particle size of liposomes influences dermal delivery of substances into skin. International Journal of Pharmaceutics. 2003; 258: 141-151.
47. Schmitt JV, Miot HA. Actinic keratosis: a clinical and epidemiological revision. Anais Brasileiros de Dermatologia. 2012; 87: 425-434.
48. Gondkar SB, Patil NR, Saudagar RB. Formulation Development and Characterization of Etodolac Loaded Transethosomes for Transdermal Delivery. Research Journal of Pharmacy and Technology. 2017; 10: 3049-3057.
49. Fadel M, Samy N, Nasr M, et al. Topical colloidal indocyanine green-mediated photodynamic therapy for treatment of basal cell carcinoma. Pharmaceutical Development and Technology. 2017; 22: 545-550.
50. Miller DL, Weinstock MA. Nonmelanoma skin cancer in the United States: incidence. Journal of the American Academy of Dermatology. 1994; 30: 774-778.
51. Rai S, Pandey V, Rai G. Transfersomes as versatile and flexible nanovesicular carriers in skin cancer therapy: the state of the art. Nano Reviews & Experiments. Published by Informa UK Limited, trading as Taylor & Francis Group. 2017; 8(1): 1325708.